0
     

Report Added
Report already added
IBS-C Drugs Market - Global Outlook and Forecast 2022-2028

IBS-C Drugs Market - Global Outlook and Forecast 2022-2028

This report contains market size and forecasts of IBS-C Drugs in global, including the following market information:

Global IBS-C Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global IBS-C Drugs Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five IBS-C Drugs companies in 2021 (%)
The global IBS-C Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Linaclotide Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of IBS-C Drugs include Catalent Pharmaceuticals Solutions, Nestle, Abbott Laboratories, Synergy Pharmaceuticals, Sucampo Pharmaceuticals, Novartis Pharma Ag, Astellas Pharmaceuticals, Ardelyx, Inc and Synthetic Biologics, Inc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the IBS-C Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:
Global IBS-C Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global IBS-C Drugs Market Segment Percentages, by Type, 2021 (%)
Linaclotide
Lubiprostone
Osmotic Laxatives
Stimulant Laxatives
Others
Global IBS-C Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global IBS-C Drugs Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global IBS-C Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global IBS-C Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies IBS-C Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies IBS-C Drugs revenues share in global market, 2021 (%)
Key companies IBS-C Drugs sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies IBS-C Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Catalent Pharmaceuticals Solutions
Nestle
Abbott Laboratories
Synergy Pharmaceuticals
Sucampo Pharmaceuticals
Novartis Pharma Ag
Astellas Pharmaceuticals
Ardelyx, Inc
Synthetic Biologics, Inc
Teva Pharmaceutical Industries
Bama-Geve, SLU
Ferring BV
Ironwood Pharmaceuticals, Inc
Salix Pharmaceuticals Ltd
Norgine B.V
Prometheus Laboratories Inc
Actavis Nordic A/S
Albireo Pharma Inc
Yuhan Corp
Astrazeneca Plc
The Menarini Group
Ono Pharmaceutical Co., Ltd
Table of Contents

1 Introduction to Research & Analysis Reports
1.1 IBS-C Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global IBS-C Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global IBS-C Drugs Overall Market Size
2.1 Global IBS-C Drugs Market Size: 2021 VS 2028
2.2 Global IBS-C Drugs Revenue, Prospects & Forecasts: 2017-2028
2.3 Global IBS-C Drugs Sales: 2017-2028
3 Company Landscape
3.1 Top IBS-C Drugs Players in Global Market
3.2 Top Global IBS-C Drugs Companies Ranked by Revenue
3.3 Global IBS-C Drugs Revenue by Companies
3.4 Global IBS-C Drugs Sales by Companies
3.5 Global IBS-C Drugs Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 IBS-C Drugs Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers IBS-C Drugs Product Type
3.8 Tier 1, Tier 2 and Tier 3 IBS-C Drugs Players in Global Market
3.8.1 List of Global Tier 1 IBS-C Drugs Companies
3.8.2 List of Global Tier 2 and Tier 3 IBS-C Drugs Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global IBS-C Drugs Market Size Markets, 2021 & 2028
4.1.2 Linaclotide
4.1.3 Lubiprostone
4.1.4 Osmotic Laxatives
4.1.5 Stimulant Laxatives
4.1.6 Others
4.2 By Type - Global IBS-C Drugs Revenue & Forecasts
4.2.1 By Type - Global IBS-C Drugs Revenue, 2017-2022
4.2.2 By Type - Global IBS-C Drugs Revenue, 2023-2028
4.2.3 By Type - Global IBS-C Drugs Revenue Market Share, 2017-2028
4.3 By Type - Global IBS-C Drugs Sales & Forecasts
4.3.1 By Type - Global IBS-C Drugs Sales, 2017-2022
4.3.2 By Type - Global IBS-C Drugs Sales, 2023-2028
4.3.3 By Type - Global IBS-C Drugs Sales Market Share, 2017-2028
4.4 By Type - Global IBS-C Drugs Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
5.1 Overview
5.1.1 By Application - Global IBS-C Drugs Market Size, 2021 & 2028
5.1.2 Hospital Pharmacies
5.1.3 Retail Pharmacies
5.1.4 Online Pharmacies
5.2 By Application - Global IBS-C Drugs Revenue & Forecasts
5.2.1 By Application - Global IBS-C Drugs Revenue, 2017-2022
5.2.2 By Application - Global IBS-C Drugs Revenue, 2023-2028
5.2.3 By Application - Global IBS-C Drugs Revenue Market Share, 2017-2028
5.3 By Application - Global IBS-C Drugs Sales & Forecasts
5.3.1 By Application - Global IBS-C Drugs Sales, 2017-2022
5.3.2 By Application - Global IBS-C Drugs Sales, 2023-2028
5.3.3 By Application - Global IBS-C Drugs Sales Market Share, 2017-2028
5.4 By Application - Global IBS-C Drugs Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
6.1 By Region - Global IBS-C Drugs Market Size, 2021 & 2028
6.2 By Region - Global IBS-C Drugs Revenue & Forecasts
6.2.1 By Region - Global IBS-C Drugs Revenue, 2017-2022
6.2.2 By Region - Global IBS-C Drugs Revenue, 2023-2028
6.2.3 By Region - Global IBS-C Drugs Revenue Market Share, 2017-2028
6.3 By Region - Global IBS-C Drugs Sales & Forecasts
6.3.1 By Region - Global IBS-C Drugs Sales, 2017-2022
6.3.2 By Region - Global IBS-C Drugs Sales, 2023-2028
6.3.3 By Region - Global IBS-C Drugs Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America IBS-C Drugs Revenue, 2017-2028
6.4.2 By Country - North America IBS-C Drugs Sales, 2017-2028
6.4.3 US IBS-C Drugs Market Size, 2017-2028
6.4.4 Canada IBS-C Drugs Market Size, 2017-2028
6.4.5 Mexico IBS-C Drugs Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe IBS-C Drugs Revenue, 2017-2028
6.5.2 By Country - Europe IBS-C Drugs Sales, 2017-2028
6.5.3 Germany IBS-C Drugs Market Size, 2017-2028
6.5.4 France IBS-C Drugs Market Size, 2017-2028
6.5.5 U.K. IBS-C Drugs Market Size, 2017-2028
6.5.6 Italy IBS-C Drugs Market Size, 2017-2028
6.5.7 Russia IBS-C Drugs Market Size, 2017-2028
6.5.8 Nordic Countries IBS-C Drugs Market Size, 2017-2028
6.5.9 Benelux IBS-C Drugs Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia IBS-C Drugs Revenue, 2017-2028
6.6.2 By Region - Asia IBS-C Drugs Sales, 2017-2028
6.6.3 China IBS-C Drugs Market Size, 2017-2028
6.6.4 Japan IBS-C Drugs Market Size, 2017-2028
6.6.5 South Korea IBS-C Drugs Market Size, 2017-2028
6.6.6 Southeast Asia IBS-C Drugs Market Size, 2017-2028
6.6.7 India IBS-C Drugs Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America IBS-C Drugs Revenue, 2017-2028
6.7.2 By Country - South America IBS-C Drugs Sales, 2017-2028
6.7.3 Brazil IBS-C Drugs Market Size, 2017-2028
6.7.4 Argentina IBS-C Drugs Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa IBS-C Drugs Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa IBS-C Drugs Sales, 2017-2028
6.8.3 Turkey IBS-C Drugs Market Size, 2017-2028
6.8.4 Israel IBS-C Drugs Market Size, 2017-2028
6.8.5 Saudi Arabia IBS-C Drugs Market Size, 2017-2028
6.8.6 UAE IBS-C Drugs Market Size, 2017-2028
7 Manufacturers & Brands Profiles
7.1 Catalent Pharmaceuticals Solutions
7.1.1 Catalent Pharmaceuticals Solutions Corporate Summary
7.1.2 Catalent Pharmaceuticals Solutions Business Overview
7.1.3 Catalent Pharmaceuticals Solutions IBS-C Drugs Major Product Offerings
7.1.4 Catalent Pharmaceuticals Solutions IBS-C Drugs Sales and Revenue in Global (2017-2022)
7.1.5 Catalent Pharmaceuticals Solutions Key News
7.2 Nestle
7.2.1 Nestle Corporate Summary
7.2.2 Nestle Business Overview
7.2.3 Nestle IBS-C Drugs Major Product Offerings
7.2.4 Nestle IBS-C Drugs Sales and Revenue in Global (2017-2022)
7.2.5 Nestle Key News
7.3 Abbott Laboratories
7.3.1 Abbott Laboratories Corporate Summary
7.3.2 Abbott Laboratories Business Overview
7.3.3 Abbott Laboratories IBS-C Drugs Major Product Offerings
7.3.4 Abbott Laboratories IBS-C Drugs Sales and Revenue in Global (2017-2022)
7.3.5 Abbott Laboratories Key News
7.4 Synergy Pharmaceuticals
7.4.1 Synergy Pharmaceuticals Corporate Summary
7.4.2 Synergy Pharmaceuticals Business Overview
7.4.3 Synergy Pharmaceuticals IBS-C Drugs Major Product Offerings
7.4.4 Synergy Pharmaceuticals IBS-C Drugs Sales and Revenue in Global (2017-2022)
7.4.5 Synergy Pharmaceuticals Key News
7.5 Sucampo Pharmaceuticals
7.5.1 Sucampo Pharmaceuticals Corporate Summary
7.5.2 Sucampo Pharmaceuticals Business Overview
7.5.3 Sucampo Pharmaceuticals IBS-C Drugs Major Product Offerings
7.5.4 Sucampo Pharmaceuticals IBS-C Drugs Sales and Revenue in Global (2017-2022)
7.5.5 Sucampo Pharmaceuticals Key News
7.6 Novartis Pharma Ag
7.6.1 Novartis Pharma Ag Corporate Summary
7.6.2 Novartis Pharma Ag Business Overview
7.6.3 Novartis Pharma Ag IBS-C Drugs Major Product Offerings
7.6.4 Novartis Pharma Ag IBS-C Drugs Sales and Revenue in Global (2017-2022)
7.6.5 Novartis Pharma Ag Key News
7.7 Astellas Pharmaceuticals
7.7.1 Astellas Pharmaceuticals Corporate Summary
7.7.2 Astellas Pharmaceuticals Business Overview
7.7.3 Astellas Pharmaceuticals IBS-C Drugs Major Product Offerings
7.7.4 Astellas Pharmaceuticals IBS-C Drugs Sales and Revenue in Global (2017-2022)
7.7.5 Astellas Pharmaceuticals Key News
7.8 Ardelyx, Inc
7.8.1 Ardelyx, Inc Corporate Summary
7.8.2 Ardelyx, Inc Business Overview
7.8.3 Ardelyx, Inc IBS-C Drugs Major Product Offerings
7.8.4 Ardelyx, Inc IBS-C Drugs Sales and Revenue in Global (2017-2022)
7.8.5 Ardelyx, Inc Key News
7.9 Synthetic Biologics, Inc
7.9.1 Synthetic Biologics, Inc Corporate Summary
7.9.2 Synthetic Biologics, Inc Business Overview
7.9.3 Synthetic Biologics, Inc IBS-C Drugs Major Product Offerings
7.9.4 Synthetic Biologics, Inc IBS-C Drugs Sales and Revenue in Global (2017-2022)
7.9.5 Synthetic Biologics, Inc Key News
7.10 Teva Pharmaceutical Industries
7.10.1 Teva Pharmaceutical Industries Corporate Summary
7.10.2 Teva Pharmaceutical Industries Business Overview
7.10.3 Teva Pharmaceutical Industries IBS-C Drugs Major Product Offerings
7.10.4 Teva Pharmaceutical Industries IBS-C Drugs Sales and Revenue in Global (2017-2022)
7.10.5 Teva Pharmaceutical Industries Key News
7.11 Bama-Geve, SLU
7.11.1 Bama-Geve, SLU Corporate Summary
7.11.2 Bama-Geve, SLU IBS-C Drugs Business Overview
7.11.3 Bama-Geve, SLU IBS-C Drugs Major Product Offerings
7.11.4 Bama-Geve, SLU IBS-C Drugs Sales and Revenue in Global (2017-2022)
7.11.5 Bama-Geve, SLU Key News
7.12 Ferring BV
7.12.1 Ferring BV Corporate Summary
7.12.2 Ferring BV IBS-C Drugs Business Overview
7.12.3 Ferring BV IBS-C Drugs Major Product Offerings
7.12.4 Ferring BV IBS-C Drugs Sales and Revenue in Global (2017-2022)
7.12.5 Ferring BV Key News
7.13 Ironwood Pharmaceuticals, Inc
7.13.1 Ironwood Pharmaceuticals, Inc Corporate Summary
7.13.2 Ironwood Pharmaceuticals, Inc IBS-C Drugs Business Overview
7.13.3 Ironwood Pharmaceuticals, Inc IBS-C Drugs Major Product Offerings
7.13.4 Ironwood Pharmaceuticals, Inc IBS-C Drugs Sales and Revenue in Global (2017-2022)
7.13.5 Ironwood Pharmaceuticals, Inc Key News
7.14 Salix Pharmaceuticals Ltd
7.14.1 Salix Pharmaceuticals Ltd Corporate Summary
7.14.2 Salix Pharmaceuticals Ltd Business Overview
7.14.3 Salix Pharmaceuticals Ltd IBS-C Drugs Major Product Offerings
7.14.4 Salix Pharmaceuticals Ltd IBS-C Drugs Sales and Revenue in Global (2017-2022)
7.14.5 Salix Pharmaceuticals Ltd Key News
7.15 Norgine B.V
7.15.1 Norgine B.V Corporate Summary
7.15.2 Norgine B.V Business Overview
7.15.3 Norgine B.V IBS-C Drugs Major Product Offerings
7.15.4 Norgine B.V IBS-C Drugs Sales and Revenue in Global (2017-2022)
7.15.5 Norgine B.V Key News
7.16 Prometheus Laboratories Inc
7.16.1 Prometheus Laboratories Inc Corporate Summary
7.16.2 Prometheus Laboratories Inc Business Overview
7.16.3 Prometheus Laboratories Inc IBS-C Drugs Major Product Offerings
7.16.4 Prometheus Laboratories Inc IBS-C Drugs Sales and Revenue in Global (2017-2022)
7.16.5 Prometheus Laboratories Inc Key News
7.17 Actavis Nordic A/S
7.17.1 Actavis Nordic A/S Corporate Summary
7.17.2 Actavis Nordic A/S Business Overview
7.17.3 Actavis Nordic A/S IBS-C Drugs Major Product Offerings
7.17.4 Actavis Nordic A/S IBS-C Drugs Sales and Revenue in Global (2017-2022)
7.17.5 Actavis Nordic A/S Key News
7.18 Albireo Pharma Inc
7.18.1 Albireo Pharma Inc Corporate Summary
7.18.2 Albireo Pharma Inc Business Overview
7.18.3 Albireo Pharma Inc IBS-C Drugs Major Product Offerings
7.18.4 Albireo Pharma Inc IBS-C Drugs Sales and Revenue in Global (2017-2022)
7.18.5 Albireo Pharma Inc Key News
7.19 Yuhan Corp
7.19.1 Yuhan Corp Corporate Summary
7.19.2 Yuhan Corp Business Overview
7.19.3 Yuhan Corp IBS-C Drugs Major Product Offerings
7.19.4 Yuhan Corp IBS-C Drugs Sales and Revenue in Global (2017-2022)
7.19.5 Yuhan Corp Key News
7.20 Astrazeneca Plc
7.20.1 Astrazeneca Plc Corporate Summary
7.20.2 Astrazeneca Plc Business Overview
7.20.3 Astrazeneca Plc IBS-C Drugs Major Product Offerings
7.20.4 Astrazeneca Plc IBS-C Drugs Sales and Revenue in Global (2017-2022)
7.20.5 Astrazeneca Plc Key News
7.21 The Menarini Group
7.21.1 The Menarini Group Corporate Summary
7.21.2 The Menarini Group Business Overview
7.21.3 The Menarini Group IBS-C Drugs Major Product Offerings
7.21.4 The Menarini Group IBS-C Drugs Sales and Revenue in Global (2017-2022)
7.21.5 The Menarini Group Key News
7.22 Ono Pharmaceutical Co., Ltd
7.22.1 Ono Pharmaceutical Co., Ltd Corporate Summary
7.22.2 Ono Pharmaceutical Co., Ltd Business Overview
7.22.3 Ono Pharmaceutical Co., Ltd IBS-C Drugs Major Product Offerings
7.22.4 Ono Pharmaceutical Co., Ltd IBS-C Drugs Sales and Revenue in Global (2017-2022)
7.22.5 Ono Pharmaceutical Co., Ltd Key News
8 Global IBS-C Drugs Production Capacity, Analysis
8.1 Global IBS-C Drugs Production Capacity, 2017-2028
8.2 IBS-C Drugs Production Capacity of Key Manufacturers in Global Market
8.3 Global IBS-C Drugs Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 IBS-C Drugs Supply Chain Analysis
10.1 IBS-C Drugs Industry Value Chain
10.2 IBS-C Drugs Upstream Market
10.3 IBS-C Drugs Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 IBS-C Drugs Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of IBS-C Drugs in Global Market
Table 2. Top IBS-C Drugs Players in Global Market, Ranking by Revenue (2021)
Table 3. Global IBS-C Drugs Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global IBS-C Drugs Revenue Share by Companies, 2017-2022
Table 5. Global IBS-C Drugs Sales by Companies, (K Pcs), 2017-2022
Table 6. Global IBS-C Drugs Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers IBS-C Drugs Price (2017-2022) & (USD/Pcs)
Table 8. Global Manufacturers IBS-C Drugs Product Type
Table 9. List of Global Tier 1 IBS-C Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 IBS-C Drugs Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global IBS-C Drugs Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global IBS-C Drugs Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global IBS-C Drugs Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global IBS-C Drugs Sales (K Pcs), 2017-2022
Table 15. By Type - Global IBS-C Drugs Sales (K Pcs), 2023-2028
Table 16. By Application – Global IBS-C Drugs Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global IBS-C Drugs Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global IBS-C Drugs Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global IBS-C Drugs Sales (K Pcs), 2017-2022
Table 20. By Application - Global IBS-C Drugs Sales (K Pcs), 2023-2028
Table 21. By Region – Global IBS-C Drugs Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global IBS-C Drugs Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global IBS-C Drugs Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global IBS-C Drugs Sales (K Pcs), 2017-2022
Table 25. By Region - Global IBS-C Drugs Sales (K Pcs), 2023-2028
Table 26. By Country - North America IBS-C Drugs Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America IBS-C Drugs Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America IBS-C Drugs Sales, (K Pcs), 2017-2022
Table 29. By Country - North America IBS-C Drugs Sales, (K Pcs), 2023-2028
Table 30. By Country - Europe IBS-C Drugs Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe IBS-C Drugs Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe IBS-C Drugs Sales, (K Pcs), 2017-2022
Table 33. By Country - Europe IBS-C Drugs Sales, (K Pcs), 2023-2028
Table 34. By Region - Asia IBS-C Drugs Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia IBS-C Drugs Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia IBS-C Drugs Sales, (K Pcs), 2017-2022
Table 37. By Region - Asia IBS-C Drugs Sales, (K Pcs), 2023-2028
Table 38. By Country - South America IBS-C Drugs Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America IBS-C Drugs Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America IBS-C Drugs Sales, (K Pcs), 2017-2022
Table 41. By Country - South America IBS-C Drugs Sales, (K Pcs), 2023-2028
Table 42. By Country - Middle East & Africa IBS-C Drugs Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa IBS-C Drugs Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa IBS-C Drugs Sales, (K Pcs), 2017-2022
Table 45. By Country - Middle East & Africa IBS-C Drugs Sales, (K Pcs), 2023-2028
Table 46. Catalent Pharmaceuticals Solutions Corporate Summary
Table 47. Catalent Pharmaceuticals Solutions IBS-C Drugs Product Offerings
Table 48. Catalent Pharmaceuticals Solutions IBS-C Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 49. Nestle Corporate Summary
Table 50. Nestle IBS-C Drugs Product Offerings
Table 51. Nestle IBS-C Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 52. Abbott Laboratories Corporate Summary
Table 53. Abbott Laboratories IBS-C Drugs Product Offerings
Table 54. Abbott Laboratories IBS-C Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 55. Synergy Pharmaceuticals Corporate Summary
Table 56. Synergy Pharmaceuticals IBS-C Drugs Product Offerings
Table 57. Synergy Pharmaceuticals IBS-C Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 58. Sucampo Pharmaceuticals Corporate Summary
Table 59. Sucampo Pharmaceuticals IBS-C Drugs Product Offerings
Table 60. Sucampo Pharmaceuticals IBS-C Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 61. Novartis Pharma Ag Corporate Summary
Table 62. Novartis Pharma Ag IBS-C Drugs Product Offerings
Table 63. Novartis Pharma Ag IBS-C Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 64. Astellas Pharmaceuticals Corporate Summary
Table 65. Astellas Pharmaceuticals IBS-C Drugs Product Offerings
Table 66. Astellas Pharmaceuticals IBS-C Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 67. Ardelyx, Inc Corporate Summary
Table 68. Ardelyx, Inc IBS-C Drugs Product Offerings
Table 69. Ardelyx, Inc IBS-C Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 70. Synthetic Biologics, Inc Corporate Summary
Table 71. Synthetic Biologics, Inc IBS-C Drugs Product Offerings
Table 72. Synthetic Biologics, Inc IBS-C Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 73. Teva Pharmaceutical Industries Corporate Summary
Table 74. Teva Pharmaceutical Industries IBS-C Drugs Product Offerings
Table 75. Teva Pharmaceutical Industries IBS-C Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 76. Bama-Geve, SLU Corporate Summary
Table 77. Bama-Geve, SLU IBS-C Drugs Product Offerings
Table 78. Bama-Geve, SLU IBS-C Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 79. Ferring BV Corporate Summary
Table 80. Ferring BV IBS-C Drugs Product Offerings
Table 81. Ferring BV IBS-C Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 82. Ironwood Pharmaceuticals, Inc Corporate Summary
Table 83. Ironwood Pharmaceuticals, Inc IBS-C Drugs Product Offerings
Table 84. Ironwood Pharmaceuticals, Inc IBS-C Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 85. Salix Pharmaceuticals Ltd Corporate Summary
Table 86. Salix Pharmaceuticals Ltd IBS-C Drugs Product Offerings
Table 87. Salix Pharmaceuticals Ltd IBS-C Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 88. Norgine B.V Corporate Summary
Table 89. Norgine B.V IBS-C Drugs Product Offerings
Table 90. Norgine B.V IBS-C Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 91. Prometheus Laboratories Inc Corporate Summary
Table 92. Prometheus Laboratories Inc IBS-C Drugs Product Offerings
Table 93. Prometheus Laboratories Inc IBS-C Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 94. Actavis Nordic A/S Corporate Summary
Table 95. Actavis Nordic A/S IBS-C Drugs Product Offerings
Table 96. Actavis Nordic A/S IBS-C Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 97. Albireo Pharma Inc Corporate Summary
Table 98. Albireo Pharma Inc IBS-C Drugs Product Offerings
Table 99. Albireo Pharma Inc IBS-C Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 100. Yuhan Corp Corporate Summary
Table 101. Yuhan Corp IBS-C Drugs Product Offerings
Table 102. Yuhan Corp IBS-C Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 103. Astrazeneca Plc Corporate Summary
Table 104. Astrazeneca Plc IBS-C Drugs Product Offerings
Table 105. Astrazeneca Plc IBS-C Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 106. The Menarini Group Corporate Summary
Table 107. The Menarini Group IBS-C Drugs Product Offerings
Table 108. The Menarini Group IBS-C Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 109. Ono Pharmaceutical Co., Ltd Corporate Summary
Table 110. Ono Pharmaceutical Co., Ltd IBS-C Drugs Product Offerings
Table 111. Ono Pharmaceutical Co., Ltd IBS-C Drugs Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2017-2022)
Table 112. IBS-C Drugs Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2020-2022 (K Pcs)
Table 113. Global IBS-C Drugs Capacity Market Share of Key Manufacturers, 2020-2022
Table 114. Global IBS-C Drugs Production by Region, 2017-2022 (K Pcs)
Table 115. Global IBS-C Drugs Production by Region, 2023-2028 (K Pcs)
Table 116. IBS-C Drugs Market Opportunities & Trends in Global Market
Table 117. IBS-C Drugs Market Drivers in Global Market
Table 118. IBS-C Drugs Market Restraints in Global Market
Table 119. IBS-C Drugs Raw Materials
Table 120. IBS-C Drugs Raw Materials Suppliers in Global Market
Table 121. Typical IBS-C Drugs Downstream
Table 122. IBS-C Drugs Downstream Clients in Global Market
Table 123. IBS-C Drugs Distributors and Sales Agents in Global Market

List of Figures
Figure 1. IBS-C Drugs Segment by Type
Figure 2. IBS-C Drugs Segment by Application
Figure 3. Global IBS-C Drugs Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global IBS-C Drugs Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global IBS-C Drugs Revenue, 2017-2028 (US$, Mn)
Figure 7. IBS-C Drugs Sales in Global Market: 2017-2028 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by IBS-C Drugs Revenue in 2021
Figure 9. By Type - Global IBS-C Drugs Sales Market Share, 2017-2028
Figure 10. By Type - Global IBS-C Drugs Revenue Market Share, 2017-2028
Figure 11. By Type - Global IBS-C Drugs Price (USD/Pcs), 2017-2028
Figure 12. By Application - Global IBS-C Drugs Sales Market Share, 2017-2028
Figure 13. By Application - Global IBS-C Drugs Revenue Market Share, 2017-2028
Figure 14. By Application - Global IBS-C Drugs Price (USD/Pcs), 2017-2028
Figure 15. By Region - Global IBS-C Drugs Sales Market Share, 2017-2028
Figure 16. By Region - Global IBS-C Drugs Revenue Market Share, 2017-2028
Figure 17. By Country - North America IBS-C Drugs Revenue Market Share, 2017-2028
Figure 18. By Country - North America IBS-C Drugs Sales Market Share, 2017-2028
Figure 19. US IBS-C Drugs Revenue, (US$, Mn), 2017-2028
Figure 20. Canada IBS-C Drugs Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico IBS-C Drugs Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe IBS-C Drugs Revenue Market Share, 2017-2028
Figure 23. By Country - Europe IBS-C Drugs Sales Market Share, 2017-2028
Figure 24. Germany IBS-C Drugs Revenue, (US$, Mn), 2017-2028
Figure 25. France IBS-C Drugs Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. IBS-C Drugs Revenue, (US$, Mn), 2017-2028
Figure 27. Italy IBS-C Drugs Revenue, (US$, Mn), 2017-2028
Figure 28. Russia IBS-C Drugs Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries IBS-C Drugs Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux IBS-C Drugs Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia IBS-C Drugs Revenue Market Share, 2017-2028
Figure 32. By Region - Asia IBS-C Drugs Sales Market Share, 2017-2028
Figure 33. China IBS-C Drugs Revenue, (US$, Mn), 2017-2028
Figure 34. Japan IBS-C Drugs Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea IBS-C Drugs Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia IBS-C Drugs Revenue, (US$, Mn), 2017-2028
Figure 37. India IBS-C Drugs Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America IBS-C Drugs Revenue Market Share, 2017-2028
Figure 39. By Country - South America IBS-C Drugs Sales Market Share, 2017-2028
Figure 40. Brazil IBS-C Drugs Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina IBS-C Drugs Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa IBS-C Drugs Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa IBS-C Drugs Sales Market Share, 2017-2028
Figure 44. Turkey IBS-C Drugs Revenue, (US$, Mn), 2017-2028
Figure 45. Israel IBS-C Drugs Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia IBS-C Drugs Revenue, (US$, Mn), 2017-2028
Figure 47. UAE IBS-C Drugs Revenue, (US$, Mn), 2017-2028
Figure 48. Global IBS-C Drugs Production Capacity (K Pcs), 2017-2028
Figure 49. The Percentage of Production IBS-C Drugs by Region, 2021 VS 2028
Figure 50. IBS-C Drugs Industry Value Chain
Figure 51. Marketing Channels

Report Title: IBS-C Drugs Market - Global Outlook and Forecast 2022-2028


Your Details
Valid Invalid number

SELECT A FORMAT

ADD TO CART BUY NOW

Related Report

Global Retinal Surgery Devices Market (By Device Segment, Application, Regional Analysis), Impact of COVID-19, Company Profiles, Major Deals, Strategy and Recent Developments – Forecast to 2027

Global Retinal Surgery Devices Market (By Device Segment, Application, Regional Analysis), Impact of COVID-19, Company Profiles, Major Deals, Strategy and Recent Developments – Forecast to 2027

Global Point of Care Testing (POCT) Market (By Diagnostics Segment, Mode, Platform, End Users, Region), Impact of COVID-19, Recent Developments, Company Profiles - Forecast to 2028

Global Point of Care Testing (POCT) Market (By Diagnostics Segment, Mode, Platform, End Users, Region), Impact of COVID-19, Recent Developments, Company Profiles - Forecast to 2028

Animal Wound Care Market by Product (Surgical (Sutures & Staplers, Glues), Advanced (Hydrocolloid, Hydrogel Dressings), Traditional (Tape, Dressings, Bandages), Animal Type (Cats, Dogs, Horse, Pigs), End User (Hospital, Clinics) - Global Forecast to 2027

Animal Wound Care Market by Product (Surgical (Sutures & Staplers, Glues), Advanced (Hydrocolloid, Hydrogel Dressings), Traditional (Tape, Dressings, Bandages), Animal Type (Cats, Dogs, Horse, Pigs), End User (Hospital, Clinics) - Global Forecast to 2027

Veterinary Ultrasound Market by Type (2D, 3D/4D, Doppler), Product (Portable Scanners), Technology (Contrast, Digital), Animal Type (Small, Large), Application (Gynecology, Cardiology, Orthopedics), End User (Clinics, Hospitals) - Global Forecast to 2027

Veterinary Ultrasound Market by Type (2D, 3D/4D, Doppler), Product (Portable Scanners), Technology (Contrast, Digital), Animal Type (Small, Large), Application (Gynecology, Cardiology, Orthopedics), End User (Clinics, Hospitals) - Global Forecast to 2027

Laboratory Animal Models, 3D Cultures and Organoids: Global Markets

Laboratory Animal Models, 3D Cultures and Organoids: Global Markets

Neuromodulation Market by Type (Internal (Deep Brain Stimulation, Vagus Nerve Stimulation), External (Transcranial Magnetic Stimulation)), Application (Parkinson's Disease, Depression, Urine incontinence, Epilepsy, Obesity) - Global Forecast to 2027

Neuromodulation Market by Type (Internal (Deep Brain Stimulation, Vagus Nerve Stimulation), External (Transcranial Magnetic Stimulation)), Application (Parkinson's Disease, Depression, Urine incontinence, Epilepsy, Obesity) - Global Forecast to 2027